The World Health Organization (WHO) has suspended clinical trials of hydroxychloroquine, as potential treatment for coronavirus after a publication indicated that it’s use could increase the likelihood of dying.
Director-General WHO, Tedros Adhanom Ghebreyesus, who spoke today, May 25 at a virtual press conference, said: “the WHO-backed trials had been suspended while the safety is reviewed.
“It’s important to continue to gather evidence on the efficacy and safety of hydroxychloroquine.
“We want to use it if it’s safe and efficacious, reduces mortality, reduces the length of hospitalization without increasing adverse events,” WHO Chief Scientist, Soumya Swaminathan, added at the press briefing in Geneva.
